Citra Putra Realty Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Putra Realty Tbk. trades at Rp2,790 (market cap 7.14T, 11.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 33.2K 24h volume). The key difference: Citra Putra Realty Tbk. is far larger — about 43.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (33.2K versus 11.3K). Which is the better fit depends on your goals.
| CLAY | OBAT | |
|---|---|---|
Market Cap | 7.14T | 164.65B |
Volume | 11.3K | 33.2K |
Lot | 113 | 332 |
Turnover | 31.51M | 8.02M |
Average Price | 2,788.58 | 241.64 |
Value | 31.51M | 8.02M |
Indicative Equilibrium Price | — | 238 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Putra Realty Tbk (“The Entity”) was established based on Notarial Deed of Herlina Pakpahan, S.H., No. 09 dated December 16, 2009. The majority shareholders (parent entity) of the Entity are PT Citra Putra Mandiri or better known as the OSO Group.
Read more on CLAY →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →